The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms

Psychiatry and Clinical Neurosciences
Akio HimeiHiroshi Yoneda

Abstract

The hyperactivity of dopaminergic systems is one of the major etiological hypotheses of schizophrenia. The major support for this hypothesis is that effective antipsychotic drugs bind to dopamine receptors and improve acute schizophrenic symptoms. For this reason, we investigated the allelic association between schizophrenia and polymorphisms of the DRD2 genes for the Ser/Cys311 and -141C Ins/Del. The subjects were 190 schizophrenics (120 males and 70 females) and 103 normal controls (53 males and 50 females). There were no significant differences between the patients and controls in the allele frequencies and the frequencies of the genotypes. We found no statistical association between schizophrenia and polymorphisms of the DRD2 genes for the Ser/Cys311 and -141C Ins/Del. These results indicate that the DRD2 gene may not develop schizophrenia. Next, we examined whether the genotypes influence the symptoms of schizophrenia the using Positive and Negative Symptom Scale scores. The Ser/Cys patients exhibited significantly lower positive and negative symptom scores than Ser/Ser patients. Patients with Del/Del, Ins/Del, or Ins/Ins showed higher positive symptom scores in descending order. This result suggested that the Del allele w...Continue Reading

References

Jan 1, 1990·Progress in Neurobiology·A S Horn
Sep 1, 1988·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A Carlsson
Nov 15, 1993·Biochemical and Biophysical Research Communications·M ItokawaM Toru
Mar 1, 1993·Neurochemistry International·P G Strange

❮ Previous
Next ❯

Citations

Jan 27, 2004·Schizophrenia Research·Caroline DubertretPhilip Gorwood
Oct 3, 2008·Brain : a Journal of Neurology·Alessandro BertolinoWolfgang Sadee
Aug 30, 2008·Schizophrenia Bulletin·Maria J Arranz, Shitij Kapur
Dec 16, 2005·Pharmacogenomics·Simone GuptaRitushree Kukreti
Dec 12, 2013·Biomarkers in Medicine·Brett A EnglishLarry Ereshefsky
Nov 26, 2011·Expert Review of Clinical Pharmacology·Maria J Arranz, Janet C Munro
Jan 28, 2010·Expert Opinion on Pharmacotherapy·Falk W Lohoff, Thomas N Ferraro
Apr 23, 2003·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Erik G JönssonGöran C Sedvall
Sep 14, 2010·Clinics in Laboratory Medicine·Peter P Zandi, Jennifer T Judy
Feb 18, 2010·The Psychiatric Clinics of North America·Peter P Zandi, Jennifer T Judy
Jun 27, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Norio Yasui-FurukoriSunao Kaneko
Dec 19, 2007·Journal of Psychiatric Research·Malin AleniusMargareta Hammarlund-Udenaes
Jun 24, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Stephen J GlattMing T Tsuang
Apr 25, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Vita DolzanKatja Breskvar
Feb 26, 2015·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Yuichiro WatanabeToshiyuki Someya
Sep 9, 2015·Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists·Xiaofeng ZhaoQuancheng Kan
Jun 5, 2003·The Psychiatric Clinics of North America·David Pickar
Dec 17, 2014·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Jun YaoBao-jie Wang
Feb 26, 2015·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Jun Yao, Bao-jie Wang
Nov 3, 2006·Biochimica Et Biophysica Acta·Lisa A Catapano, Husseini K Manji
Jun 11, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Yurong WangFaming Pan
Nov 11, 2016·Behavioral and Brain Functions : BBF·Thelma Beatriz González-CastroMariela Alpuin-Reyes
Apr 15, 2004·European Journal of Human Genetics : EJHG·S BaritakiD A Spandidos
Jan 13, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Stephen J Glatt, Erik G Jönsson
Jun 23, 2020·Annals of General Psychiatry·Anna MichalczykJerzy Samochowiec
Jul 27, 2007·Behavioral and Brain Functions : BBF·Neetha N VijayanMoinak Banerjee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here